Tactic Pharma LLC

Track

Insider profile

Performance

Overall performance
1.3
Performance over holding periods
1.3
30 days 90 days 120 days
Average return -28% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Tactic Pharma LLC's trades of Monopar Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
466.70
Quantity 98,573
Value US$1,478,841
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-09-26 2025-09-24
S Sale
71,564 -43.9%
31.30
US$2,092,026 		71,564 -43.9% 31.30 US$2,092,026
2025-04-04 2025-04-02
S Sale
48,540 +20.8%
214.45
US$4,912,164 		48,540 +20.8% 214.45 US$4,912,164
2025-04-02 2025-04-02
PrS Proposed sale
98,573
466.70
US$1,478,841 		98,573 466.70 US$1,478,841
2021-02-16 2021-02-11
PlS Planned sale
11,929 -6.7%
16.90
US$201,600 		11,929 -6.7% 16.90 US$201,600
2021-02-16 2021-02-11
PlS Planned sale
16,384 -8.4%
16.44
US$269,353 		16,384 -8.4% 16.44 US$269,353
2021-02-16 2021-02-11
PlS Planned sale
29,996 -13.3%
15.12
US$453,540 		29,996 -13.3% 15.12 US$453,540
2021-02-16 2021-02-11
PlS Planned sale
24,224 -9.7%
14.09
US$341,316 		24,224 -9.7% 14.09 US$341,316
2021-02-16 2021-02-11
PlS Planned sale
42,467 -14.6%
13.30
US$564,811 		42,467 -14.6% 13.30 US$564,811